Background: Interleukin-17 (IL-17), as a potent proinflammatory cytokine, has a critical role in post liver transplant outcomes. However, there is not much information about the effects of IL-17 cytokine on acute liver rejection. Objective: To evaluate the role of IL-17 in post-liver transplant acute rejection. Methods: Ninety seven adult liver transplant patients who enrolled in this cross sec...

Abstract Rituximab, an anti-CD20 agent, has been suggested as an effective strategy to deal with post transplant lymphoproliferative disorders (PTLD). In the current study, we aim to evaluate the efficacy of rituximab therapy in heart transplant population developing PTLD. A comprehensive search of the literature was performed to gather the available data on lymphoproliferative disorders oc...

Cyclosporin and azathioprine are immunosuppressive drugs, used widely in kidney transplant patients. A significant association between immunosuppressive therapy and multiple warts was described several years ago. There are also some reports of sebaceous gland hyperplasia in kidney transplant patients receiving cyclosporin. We report herein a 57-year-old woman who developed multiple warts on her...

Cutaneous leishmaniasis may present as unusual manifestations in renal transplant patients receiving immunosuppressive therapy. This misleading presentation, may delay the diagnosis and treatment. Moreover special caution must be taken in renal transplant recipients because of possible interactions between antimony compounds and cyclosporine metabolites. We report a 45-year old man with 5 years...

PurposeTransplant center volume is associated with improved survival after isolated heart transplant, but its impact on multiorgan transplant outcomes unknown. This study examines the of institutional outcomes.MethodsAdult patients undergoing first time from 2011-2021 were identified in United Network for Organ Sharing database. For each year, centers classified as low-, medium-, or high-volume...

INTRODUCTION Patients who survive the initial post-liver transplantation period face the development of chronic diseases in the long run. We studied two important complications of liver transplantation, namely: renal impairment and diabetes mellitus. METHODS We analysed adult patients followed-up for more than one year using data from our liver transplant clinical records. Long-term post-tran...

PurposePre-transplant antiphospholipid antibodies (aPLab), including anticardiolipin (aCL) and anti-B2 glycoprotein-I (aB2GPI), may be associated with thrombotic complications graft loss in kidney liver transplant recipients. The objective of this study was to evaluate the prevalence impact aPLab on post-operative bleeding lung recipients.MethodsThis a single center retrospective cohort patient...

Background Optimizing immunosuppression in lung transplant recipients (LTR) is crucially important minimizing the risk of infection and rejection. Quantiferon®-Monitor (QFM) a candidate immune function biomarker which has not yet been rigorously evaluated setting. The aim this prospective cohort study was to explore relationships between QFM results, immunosuppression, infection/rejection LTR. ...